Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2247 ARTÍCULOS , VIENDO DEL 751 AL 765

Plasma exchange with albumin replacement for Alzheimer's disease treatment induced changes in serum and cerebrospinal fluid inflammatory mediator levels

Gonzalo R, Minguet C, Ortiz AM, Bravo MI, López OL, Boada M, Ruiz A, Costa M.

Ann Clin Transl Neurol. 2024 Dec;11(12):3280-3291. doi: 10.1002/acn3.52235. Epub 2024 Oct 30.

Indole-based COX-2 inhibitors: A decade of advances in inflammation, cancer, and Alzheimer's therapy

Shah M, Parmar R, Patel K, Nagani A.

Bioorg Chem. 2024 Dec;153:107931. doi: 10.1016/j.bioorg.2024.107931. Epub 2024 Oct 29.

Gut microbiome and Alzheimer's disease: What we know and what remains to be explored

Kapoor B, Biswas P, Gulati M, Rani P, Gupta R.

Ageing Res Rev. 2024 Dec;102:102570. doi: 10.1016/j.arr.2024.102570. Epub 2024 Oct 30.

Assessing the Role of the Generative Pretrained Transformer (GPT) in Alzheimer's Disease Management: Comparative Study of Neurologist- and Artificial Intelligence-Generated Responses

Zeng J, Zou X, Li S, Tang Y, Teng S, Li H, Wang C, Wu Y, Zhang L, Zhong Y, Liu J, Liu S.

J Med Internet Res. 2024 Oct 31;26:e51095. doi: 10.2196/51095.

Convergence between brain aging and Alzheimer's disease: Focus on mitochondria

Vaiasicca S, Balietti M, Bevilacqua L, Giorgetti B, Casoli T.

Mech Ageing Dev. 2024 Dec;222:112001. doi: 10.1016/j.mad.2024.112001. Epub 2024 Oct 28.

Lifestyle empowerment for Alzheimer's prevention prescribed by physicians: Methods and adaptations to COVID-19

Szabo-Reed AN, Watts A, Vidoni ED, Mahnken J, Van Sciver A, Finley K, Clutton J, Holden R, Key MN, Burns JM.

Contemp Clin Trials. 2024 Dec;147:107729. doi: 10.1016/j.cct.2024.107729. Epub 2024 Nov 2.

A Comprehensive Analysis on Galantamine Based Hybrids for the Management of Alzheimer's Disease

Singh YP, Prasad S, Kumar H.

Chem Biol Drug Des. 2024 Oct;104(5):e70004. doi: 10.1111/cbdd.70004.

Keep neuroinflammation in mind when addressing Alzheimer's disease: A microglia perspective

Gessi S, Mirandola P, Merighi S.

J Alzheimers Dis. 2024 Nov;102(2):314-316. doi: 10.1177/13872877241290693. Epub 2024 Nov 3.

Involvement of inflammasomes in the pathogenesis of Alzheimer's disease

Beder N, Belkhelfa M, Leklou H.

J Alzheimers Dis. 2024 Nov;102(1):11-29. doi: 10.1177/13872877241283677. Epub 2024 Oct 3.

The Double-Edged Effects of Substance P in the Pathology of Alzheimer's Disease

Lin Z, Yu S, Yang Y, Mu H, Hu Y, Yu W, Lü Y.

Aging Dis. 2024 Oct 15;16(5):2870-2889. doi: 10.14336/AD.2024.0960.

Systemic Modulators: Potential Mechanism for the 5-HT System to Mediate Exercise Amelioration in Alzheimer's Disease

Wu Q, He Q, Zhang X, Chen S, Xue X.

Aging Dis. 2024 Sep 30;16(5):2770-2802. doi: 10.14336/AD.2024.0834.

Neurocognitive effects of proanthocyanidin in Alzheimer's disease: a systematic review of preclinical evidence

Reshma A, Subramanian A, Kumarasamy V, Tamilanban T, Sekar M, Gan SH, Subramaniyan V, Wong LS, Rani NNIM, Wu YS.

Braz J Med Biol Res. 2024 Nov 4;57:e13587. doi: 10.1590/1414-431X2024e13587. eCollection 2024.

Therapeutic role of NLRP3 inflammasome inhibitors against Alzheimer's disease

Tantra T, Rahaman T A A, Nandini, Chaudhary S.

Bioorg Chem. 2024 Dec;153:107912. doi: 10.1016/j.bioorg.2024.107912. Epub 2024 Oct 23.

Prevention and Treatment of Alzheimer's Disease Via the Regulation of the Gut Microbiota With Traditional Chinese Medicine

Long J, Zhang J, Zeng X, Wang M, Wang N.

CNS Neurosci Ther. 2024 Nov;30(11):e70101. doi: 10.1111/cns.70101.

Redox regulation, protein S-nitrosylation, and synapse loss in Alzheimer's and related dementias

Oh CK, Nakamura T, Zhang X, Lipton SA.

Neuron. 2024 Dec 4;112(23):3823-3850. doi: 10.1016/j.neuron.2024.10.013. Epub 2024 Nov 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias